Aclarion Inc.

0.05
0.01 (31.58%)
At close: Apr 04, 2025, 3:56 PM
0.05
0.00%
After-hours: Apr 04, 2025, 04:00 PM EDT

Company Description

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States.

It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software.

The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021.

Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Aclarion Inc.
Aclarion Inc. logo
Country United States
IPO Date n/a
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 4
CEO Brent Ness

Contact Details

Address:
951 Mariners Island Boulevard
San Mateo, California
United States
Website https://www.aclarion.com

Stock Details

Ticker Symbol ACONW
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001635077
CUSIP Number 655187110
ISIN Number US6551871105
Employer ID 47-3324725
SIC Code 8071

Key Executives

Name Position
Brent Ness Chief Executive Officer, President & Director
John Lorbiecki Chief Financial Officer
Dr. Jeffrey John Thramann M.D. Executive Chairman
Ryan Bond Chief Strategy Officer

Latest SEC Filings

Date Type Title
Mar 31, 2025 NT 10-K Filing
Mar 28, 2025 8-K Current Report
Mar 13, 2025 8-K Current Report
Mar 06, 2025 8-K Current Report
Feb 28, 2025 8-K Current Report
Feb 28, 2025 DEFA14A Filing
Feb 13, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 03, 2025 DEF 14A Filing
Jan 31, 2025 8-K Current Report
Jan 31, 2025 424B5 Filing